Related Experiment Video
Updated: Aug 5, 2026

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
Published on: April 12, 2019
[Parapneumonic pleural effusion: an 11-year review]
L Deiros Bronte1, F Baquero-Artigao, María J García-Miguel
1Servicio de Enfermedades Infecciosas, Hospital Universitario Infantil La Paz, Madrid, Spain. brontemaria@yahoo.es
Insights
The incidence of pediatric parapneumonic effusions significantly increased from 1993 to 2003. Streptococcus pneumoniae was the most common cause, showing low penicillin resistance.
Area of Science:
- Pediatric Infectious Diseases
- Pulmonology
- Epidemiology
Context:
- Community-acquired pneumonia (CAP) in children can lead to parapneumonic effusions (PPE).
- Recent years have seen a potential rise in pediatric PPE cases.
- Understanding the incidence and clinical features of PPE is crucial for effective management.
Purpose:
- To determine the clinical features and incidence of pediatric parapneumonic effusions over an 11-year period (1993-2003).
- To analyze trends in PPE incidence within a specific geographic area and hospital setting.
Summary:
- A retrospective review of 130 pediatric patients with PPE (aged <15 years) was conducted.
- The incidence of PPE significantly increased from 1993 to 2003, both per 100,000 children and per 100 hospitalized children.
- Streptococcus pneumoniae was the most frequent causative organism, with high susceptibility to penicillin.
Impact:
- Highlights a significant upward trend in pediatric parapneumonic effusions, necessitating further investigation into contributing factors.
- Provides data on common pathogens and treatment outcomes, aiding clinical decision-making.
- Emphasizes the continued effectiveness of penicillin for Streptococcus pneumoniae infections causing PPE.
Introduction:
In the last few years, the incidence of parapneumonic effusions in children with community-acquired pneumonia seems to have increased. The aim of this study was to determine the clinical features and incidence of parapneumonic effusions throughout an 11-year period.
Material And Methods:
We retrospectively reviewed the medical records of patients aged < 15 years old with parapneumonic effusions from 1993 to 2003. Annual incidence rates were calculated per 100,000 children < 15 years old from Health Area 5 of Madrid and per 100 children hospitalized in the Infectious Diseases Department of our hospital. The linear association test was used to compare the incidence rates over the previous 11 years.
Results:
There were 130 patients with parapneumonic pleural effusions. The mean age was 4.7 years. Forty-one percent received antibiotics before diagnosis. The causative organisms were identified in 42 patients (32.3%). The most effective diagnostic method was pleural-fluid culture (18/58, 31%). The most common organisms were Streptococcus pneumoniae (18), Mycoplasma pneumoniae (8), Staphylococcus aureus (4), Streptococcus pyogenes (3), Haemophilus influenzae (3) and Mycobacterium tuberculosis (2). Thirty-two percent of the patients required pleural drainage and 16% underwent video-assisted thoracoscopic surgery. Of 12 S. pneumoniae antibiograms available, 91.7% showed full susceptibility to penicillin and 75% were susceptible to erythromycin. The annual incidence of parapneumonic effusions rose from 18.1 in 1993 to 42.9 in 2003 (p < 0.001) per 100,000 children and from 0.76 in 1993 to 3.3 in 2003 (p < 0.001) per 100 children hospitalized in our unit.
Conclusion:
The incidence of parapneumonic effusions in children with community-acquired pneumonia showed a statistically significant increase between 1993 and 2003. The most common causal organism was S. pneumoniae, with a low rate of penicillin resistance.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pneumothorax II: Pathophysiology

